Hereditary Cancer NGS Testing: Benefits, Challenges, Methods and Considerations
The introduction of next-generation sequencing (NGS) technology in testing for hereditary cancer susceptibility allows testing of multiple cancer susceptibility genes simultaneously. While there are many potential benefits to utilizing this technology in the hereditary cancer clinic, including efficiency of time and cost, there are also important limitations that must be considered.
Download this free compendium containing 5 application notes to learn:
When to use multi-gene panel testing for hereditary cancer
How to overcome challenges of variant annotation in hereditary cancer
What software solutions are available for hereditary cancer variant
How to manage incidental findings in hereditary cancer
Best practices for NGS test reporting in hereditary cancer
Thank you
* Mandatory fields
† Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting, phone calls and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws including the EU General Data Protection Regulation All information you provide in this site will be governed by our Privacy Policy.
